Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus (Q46874592)
Jump to navigation
Jump to search
scientific article published in November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus |
scientific article published in November 2007 |
Statements
1 reference
Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus (English)
1 reference
Aaron S Kelly
1 reference
Andrea M Thelen
1 reference
Daniel R Kaiser
1 reference
J Michael Gonzalez-Campoy
1 reference
Alan J Bank
1 reference
1 November 2007
1 reference
1 reference
12
1 reference
311-318
1 reference
4
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference